Welcome to Valicare!
Do you have questions about the GMP compliance of your ATMP? Or are you looking for a turnkey production solution for your ATMP? Take a look at the services our experts offer or contact us directly.Learn more
Events where you can meet Valicare experts
28 Mar 202231 Mar 2022Rotterdam, Netherland 13 PBP World Meeting, 2022 The PBP World Meeting on pharmaceuticals, biopharmaceuticals and pharmaceutical technology will be held in Rotterdam, pandemic permitting. Visit Valicare at booth 66.
04 May 202205 May 2022Hamburg, Germany DBT, 2022 In plenary sessions and symposia, the conference will highlight current developments in medical and industrial biotechnology as well as the framework conditions for this innovative industry.
17 May 202218 May 2022Frankfurt am Main, Germany ATMP, 2022 The conference "Advanced Therapies - Challenges for Routine Applications", organized by the Dechema, is dedicated to advances in the development and production of cell and gene therapeutics as well as quality control methods and specific regulatory requirements.
Nachrichten aus aller Welt
Unser internationaler Pressespiegel zeigt eine Auswahl an Nachrichten und neusten Artikel zu den Themen Arzneimittel neuartiger Therapien (ATMP), Chimäre Antigenrezeptor(CAR)-T-Zell-Therapie, Tumor infiltrierende Lymphozyten (TIL) und biotechnologisch bearbeitete Gewebeprodukte (TEP).
Current Frontline Treatment of Diffuse Large B-Cell Lymphoma21.01.2022 | BFN Today
This review article discusses which frontline treatment are best for diffuse large B-cell lymphoma.
Top Process Development Trends for 2021 and a Look into 202221.01.2022 | Process Development Forum
The COVID-19 pandemic continues to shape bioprocess development trends, and many lessons have been learned from industry’s response to and ...
Förderpreisgelder unterstützen die Würzburger Krebsforschung21.01.2022 | Krebs-Nachrichten
Stem cells or their exosomes: which is preferred in COVID-19 treatment?20.01.2022 | U.S. National Library of Medicine
It only took 8 months for the pneumonia caused by a previously unknown coronavirus to turn into a global pandemic of unprecedentedly far- ...
Alternativer SARS-CoV-2 Infektionsweg über Hirngefäße identifiziert20.01.2022 | News-Research
Bristol Myers Squibb : Receives Approval for Abecma (idecabtagene vicleucel), the First CAR T Therapy Approved for the Treatment of Multiple Myeloma in Japan20.01.2022 | Market Screener
TOKYO, January 20, 2022 -- Bristol-Myers Squibb K.K. today announced that Japan's Ministry of Health, Labour and Welfare has approved ...
Marker Therapeutics : Receives FDA Orphan Drug Designation for its Multi-Antigen Targeted T Cell Therapy for Pancreatic Cancer - Form 8-K20.01.2022 | Market Screener
Marker Therapeutics Receives FDA Orphan Drug Designation for its Multi-Antigen Targeted T Cell Therapy for Pancreatic Cancer ...
Ergebnisse der klinischen Phase 1/2 Studie mit ABX196 zur Behandlung von Leberkrebs19.01.2022 | Krebs-Nachrichten
Actemra/RoActemra approved by the European Commission to treat patients with severe COVID-1919.01.2022 | Canadian Life Sciences Database
Increasing the capacity of the immune system to kill cancer cells18.01.2022 | Latest Todayuknews & Updates - Todayuknews
Awakening the immune system’s instinct for destroying cancer, using two molecules located on the surface of macrophages: that’s the ...
The Role of miRNA in Tumor Immune Escape and miRNA-Based Therapeutic Strategies18.01.2022 | Frontiers
Tumor immune escape is a critical step in the malignant progression of tumors and one of the major barriers to immunotherapy, making ...
Therapeutic potential of CAR T cell in malignancies: A scoping review15.01.2022 | Science Direct
Highlights • CAR-T cell therapy is one of several treatments included in cancer immunotherapy. • CAR T cells have been categorized into ...
Gene therapy: from catastrophe to cure in 20 years13.01.2022 | The Pharmaceutical Journal
After several setbacks since its inception over 30 years ago, in vivo gene therapy is starting to make some significant headway, with new ...
Should CAR T Cells Be Used Earlier in People with Non-Hodgkin Lymphoma?13.01.2022 | National Cancer Institute
January 13, 2022 , by NCI Staff Several approved CAR T-cell therapies work by binding to the CD19 antigen on cancer cells and killing ...
A Group of Innovative Orphan Drugs Win FDA Approval in 2021 - Global Genes12.01.2022 | Global Genes
Rare Daily Staff The U.S. Food and Drug Administration approved 26 novel orphan drugs in 2021, down from 31 novel Rare Daily Staff The U.S ...